Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term persistence study of live attenuated varicella vaccine at 5 and 8 years after primary immunization
CTR20212688Phase 4Active
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Dec 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of varicella vaccine live in chickenpox (2 arms), sponsored by Sinovac Biotech Ltd. Primary endpoints: Varicella antibody seropositivity rate at year 5 after primary immunization, Varicella antibody geometric mean titer at year 5 after primary immunization and 2 more. Started Dec 2021; status: active.
02
Drugs
varicella vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on CTR20212688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20212688.